Choosing the right renal diet for a cat with chronic kidney disease (CKD) is one of the most impactful decisions in long-term disease management. Phosphorus-restricted therapeutic diets are the single most evidence-supported nutritional intervention for slowing CKD progression — yet not all renal diets are equivalent. They differ meaningfully in phosphorus content, protein quality and quantity, omega-3 fatty acid levels, moisture content, and — crucially — palatability.
This guide breaks down the leading prescription renal diets available for cats across the key clinical parameters that matter for CKD management. It is designed to be read alongside a veterinarian’s guidance, not as a replacement for it — the right diet for any individual cat depends on their IRIS stage, concurrent conditions, body weight, and what they will actually eat.
| Why Diet Is So Important in Feline CKD Phosphorus restriction is the single most evidence-supported dietary intervention for slowing CKD progression. A landmark randomised controlled trial (Ross et al., 2006) demonstrated that cats fed a renal diet survived significantly longer than cats fed a standard maintenance diet. However, a renal diet the cat refuses to eat provides zero benefit — palatability must always be part of the selection process. |
What to Look for in a Renal Diet: Key Parameters
| Parameter | Why It Matters | Target for CKD Cats |
| Phosphorus (dry matter) | Excess phosphorus accelerates renal secondary hyperparathyroidism and nephron loss | < 0.5% DM (IRIS Stage 2–3); < 0.4% DM (Stage 3–4) |
| Protein (dry matter) | Reduced but high-quality protein lowers uraemic toxin burden without causing malnutrition | 28–35% DM; biological value (digestibility) more important than quantity alone |
| Omega-3 fatty acids (EPA + DHA) | Anti-inflammatory effect on glomerular tissue; reduces proteinuria | > 0.4% DM combined EPA + DHA (wet weight basis for wet food) |
| Moisture content | Supports hydration; reduces uraemic toxin concentration; improves urine dilution | Wet food preferred: 75–80% moisture vs. 8–12% in kibble |
| Sodium | Excess sodium contributes to hypertension; moderate restriction recommended | Moderate restriction: 0.2–0.4% DM; avoid severe restriction |
| Potassium | Hypokalaemia is common in CKD cats; diet should not restrict potassium | Adequate or supplemented: > 0.6% DM |
| Caloric density | CKD cats frequently lose body weight; diet must maintain adequate caloric intake | High enough to maintain body condition score 4–5/9 without overfeeding |
The Leading Prescription Renal Diets: A Comparative Overview
The following comparison covers the three major prescription renal diet brands with the most extensive clinical use and published evidence in feline CKD. Each section provides a clinical profile, key nutritional parameters, palatability notes, and a recommendation for the clinical scenario where each product tends to perform best.
1. Hill’s Prescription Diet k/d — Feline
Hill’s k/d (kidney diet) is the original and most extensively studied feline prescription renal diet, backed by the landmark 2006 Ross et al. clinical trial that demonstrated significantly longer survival in CKD cats. It is available in both wet (pouch and can) and dry formulations. The wet formulations are strongly preferred for CKD management due to moisture content and palatability advantages.
| Parameter | k/d Wet (Chicken) | k/d Dry | Clinical Note |
| Phosphorus (%DM) | 0.35% | 0.52% | Both meet IRIS Stage 2–3 targets; wet formulation preferred for Stage 3–4 |
| Protein (%DM) | 34.5% | 29.8% | Adequate for muscle mass preservation; high biological quality egg/chicken protein |
| Omega-3 EPA+DHA | 0.42% (wet wt.) | 0.4% (DM) | Meets therapeutic omega-3 targets in both formulations |
| Moisture | 78% | 9% | Wet formulation strongly preferred for CKD hydration support |
| Sodium (%DM) | 0.34% | 0.37% | Appropriate moderate restriction |
| Caloric density | 950 kcal/kg (wet) | 3,466 kcal/kg (dry) | Wet formulation requires larger feeding volumes for caloric adequacy |
- Best for: Cats at IRIS Stage 2–3 with good appetite. The most evidence-backed formulation with RCT survival data. Multiple flavour options (chicken, tuna, ocean fish, turkey) improve acceptance in finicky cats.
- Palatability rating: Generally good; tuna and ocean fish variants tend to have highest acceptance in clinical experience.
2. Royal Canin Renal — Feline
Royal Canin Renal is a widely used alternative with strong clinical acceptance. A distinguishing feature is its formulation approach — Royal Canin offers more product variants within the renal range than Hill’s, including formulations specifically designed for early-stage CKD, cats with concurrent cardiac disease, cats with reduced appetite, and cats requiring urinary pH management alongside renal support.
| Formulation | Key Differentiator | Best Clinical Scenario |
| Renal — original (wet/dry) | Standard renal formulation; good phosphorus restriction | IRIS Stage 2–3; primary renal management |
| Renal Early Consult | Higher protein content; less severe phosphorus restriction | IRIS Stage 1–2; early CKD where muscle mass preservation is priority |
| Renal Special (dry) | Very high palatability formulation for anorexic/finicky cats | Cats refusing standard renal diets; late-stage CKD with appetite reduction |
| Renal + Cardiac | Low sodium alongside renal formulation | CKD cats with concurrent cardiac disease or significant hypertension |
- Best for: Cats requiring dietary variation within the renal category; cats with concurrent conditions requiring combined dietary management. The ‘Renal Special’ dry formulation is particularly useful for cats that are difficult to maintain on wet food.
- Palatability rating: Excellent across most variants; consistently rated highly by owners managing finicky eaters.
3. Purina Pro Plan Veterinary Diets NF (Kidney Function)
Purina’s NF (Neuro/Nutraceutical Function) range offers a competitive renal diet with a formulation approach emphasising antioxidant nutrients (vitamin E, lutein) and moderate protein restriction. It is available in wet and dry formats. Published clinical data on feline CKD survival with Purina NF are more limited than for Hill’s k/d, though the formulation meets the key phosphorus and protein targets.
| Parameter | NF Wet | NF Dry | Clinical Note |
| Phosphorus (%DM) | 0.34% | 0.42% | Meets Stage 2–3 targets; wet formulation preferred |
| Protein (%DM) | 30.8% | 26.0% | Somewhat lower protein than Hill’s k/d; monitor for muscle wasting |
| Omega-3 EPA+DHA | 0.35% (wet wt.) | 0.31% (DM) | Slightly below optimal omega-3 target; fish oil supplementation may be beneficial |
| Moisture | 76% | 8% | Standard for wet/dry comparison |
| Caloric density | 880 kcal/kg (wet) | 3,280 kcal/kg (dry) | Adequate for weight maintenance in most CKD cats |
- Best for: Budget-conscious owners seeking a clinically appropriate alternative to Hill’s or Royal Canin. Consider fish oil supplementation (50–100 mg/kg/day EPA+DHA) to optimise omega-3 intake.
- Palatability rating: Good; palatability is generally slightly below Hill’s k/d in clinical comparison but still well accepted by most cats.
When Prescription Diets Are Refused: Practical Alternatives
A renal diet that a cat categorically refuses to eat provides zero therapeutic benefit. In cats that will not accept any prescription renal formulation despite adequate transition time and multiple flavour trials, a practical compromise may be necessary:
- Add a phosphate binder: Aluminium hydroxide, lanthanum carbonate (Renalzin), or calcium carbonate added to any diet — including non-prescription food — substantially reduces net phosphorus absorption. This is not as effective as a full renal diet but is significantly better than no phosphorus management at all.
- High-quality wet food as a base: Choose a wet food with the lowest available phosphorus content (ideally below 0.7% DM), add phosphate binder, supplement with fish oil, and monitor blood phosphorus at each follow-up.
- Home-prepared renal diet: A recipe formulated by a board-certified veterinary nutritionist (ACVN/ECVCN) can be phosphorus-appropriate and highly palatable. Resources: BalanceIT.com, ASPCA’s Pet Nutrition Alliance.
Summary Comparison
| Diet | Phosphorus Control | Palatability | Variant Range | Best Scenario | Evidence Level |
| Hill’s k/d wet | Excellent | Very good | 5+ flavours | Stage 2–3; evidence-backed first line | RCT data |
| RC Renal | Excellent | Excellent | Largest range | Concurrent conditions; finicky cats | Clinical use |
| Purina NF wet | Very good | Good | Limited | Budget option; supplement omega-3 | Limited RCT |
| RC Renal Special | Good | Outstanding | 1 dry variant | Dry-food-only cats; anorexic cats | Clinical use |
| Phosphate binder + any wet | Good (with binder) | Excellent (cat’s choice) | Unlimited | Diet refusal; Stage 2 with good appetite | Indirect |
Key Takeaways
- Phosphorus-restricted wet renal diets are the most evidence-supported dietary intervention for slowing CKD progression in cats
- Hill’s k/d wet has the strongest published clinical trial evidence; Royal Canin Renal offers the broadest variant range for difficult cases
- Palatability must be assessed individually — multiple flavour trials and gradual transition improve acceptance rates substantially
- When prescription renal diets are refused, phosphate binders added to any wet food represent a clinically meaningful compromise
- Omega-3 supplementation (EPA+DHA) is worth adding to any renal diet that does not fully meet the 0.4% DM target
- Renal diet selection should be revisited at each monitoring appointment as disease stage and palatability preferences change
References
1. Ross SJ et al. (2006). Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 229(6):949–57.
2. Sparkes AH et al. (2016). ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. J Feline Med Surg 18(3):219–39.
3. Elliott J, Barber PJ (1998). Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 39(2):78–85.
4. Brown SA et al. (1998). Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 9(12):2219–26.
5. Plantinga EA et al. (2005). Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 157(7):185–7.
6. IRIS (2023). IRIS staging of CKD and treatment recommendations. www.iris-kidney.com